JENNIFER PRICE: Open Payments
NPI 1881943694 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 38 payments from 7 companies in 2025. Trend: 2023 $375 · 2024 $211 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $339 |
| ABBVIE INC. | 15 | $250 |
| UCB, Inc. | 5 | $93 |
| Dexcom, Inc. | 3 | $60 |
| United Therapeutics Corporation | 1 | $31 |
| Novo Nordisk Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: KRYSTEXXA, RINVOQ, Bimzelx, SKYRIZI, OTEZLA, Dexcom G6 Transmitter, TAVNEOS, DALVANCE.
Industry payments across LA — which companies pay providers there.
